IMMUNITYBIO, INC.

Lobbying client. Federal LDA filings.

Source id: 69499
General description: Immunotherapy company focused on developing treatments for cancer and infectious diseases.
State: CA
Country: US
Principal place of business: US
Effective date: 2025-10-01
Total spend (across 1 ingested filings): $60,000

Filings (1) — $60,000

Posted	Type	Year	Lobbying firm	Income
2026-04-18	`Q1Y`	2026	CONTINENTAL STRATEGY, LLC	$60,000

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.